EKF Diagnostics Holdings (EKF)

Sector:

Financials

Index:

FTSE AIM All-Share

34.70p
   
  • Change Today:
      0.100p
  • 52 Week High: 85.00p
  • 52 Week Low: 33.40p
  • Currency: UK Pounds
  • Shares Issued: 454.93m
  • Volume: 261,942
  • Market Cap: £157.86m

EKF Overview

EKF Diagnostics is a global medical manufacturer of point-of-care and central lab devices and chemistry reagents including hemoglobin tests, HbA1c tests, glucose and lactate tests.
Competitors: Physiomics, SDI Group , Polarean Imaging
Registrars: Capita Registrars

Key Personnel

CEO: David Michael Salter
CFO: Marc Davies
Non-Executive Chairman: Christopher H B Mills
Non-Executive Deputy Chairman: Julian Baines
Non-Executive Dir: Christian Alexander Rigg , Jenny Winter

Contact Details

Address: Avon House, 19 Stanwell Road, Penarth, Cardiff, United Kingdom, CF64 2EZ
Phone: +44 (0)29 20 710570
Fax: +44 (0)29 20 705715
Website: http://www.ekfdiagnostics.com

Listings

Sector: Financials(LSE)
Index: FTSE AIM All-Share
ISIN: GB0031509804

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

EKF Market Data

Currency UK Pounds
Share Price 34.70p
Change Today 0.100p
% Change 0.29 %
52 Week High 85.00p
52 Week Low 33.40p
Volume 261,942
Shares Issued 454.93m
Market Cap £157.86m

EKF Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
24.23% below the market average24.23% below the market average24.23% below the market average24.23% below the market average24.23% below the market average
61.98% below the sector average61.98% below the sector average61.98% below the sector average61.98% below the sector average61.98% below the sector average
Price Trend
85.92% below the market average85.92% below the market average85.92% below the market average85.92% below the market average85.92% below the market average
89.78% below the sector average89.78% below the sector average89.78% below the sector average89.78% below the sector average89.78% below the sector average
Income
58.60% above the market average58.60% above the market average58.60% above the market average58.60% above the market average58.60% above the market average
32.47% below the sector average32.47% below the sector average32.47% below the sector average32.47% below the sector average32.47% below the sector average
Growth
86.34% above the market average86.34% above the market average86.34% above the market average86.34% above the market average86.34% above the market average
73.11% above the sector average73.11% above the sector average73.11% above the sector average73.11% above the sector average73.11% above the sector average

What The Brokers Say

Strong Buy 3
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 3
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

EKF Dividends

  Latest Previous
  Final Final
Ex-Div 03-Nov-22 04-Nov-21
Paid 01-Dec-22 01-Dec-21
Amount 1.20p 1.10p

Trades for 18-May-2022

Time Volume / Share Price
12:40 417 @ 34.70p
12:40 10,476 @ 34.90p
12:40 11 @ 34.80p
12:40 678 @ 34.70p
12:39 11,081 @ 34.90p

EKF Key Personnel

CEO David Michael Salter
CFO Marc Davies

Top of Page